| Autor: |
Johannes, Mischinger, Helmut, Schöllnast, Hanna, Zurl, Mark, Geyer, Katja, Fischereder, Gabriel, Adelsmayr, Jasminka, Igrec, Gerald, Fritz, Martina, Merdzo-Hörmann, Jörg, Elstner, Johannes, Schmid, Alfred, Triebl, Viktoria, Trimmel, Clemens, Reiter, Jakob, Steiner, Dominik, Rosenlechner, Maximilian, Seles, Georg P, Pichler, Martin, Pichler, Jakob, Riedl, Stephanie, Schöpfer-Schwab, Jakob, Strobl, Georg C, Hutterer, Richard, Zigeuner, Karl, Pummer, Herbert, Augustin, Sascha, Ahyai, Sebastian, Mannweiler, Michael, Fuchsjäger, Emina, Talakic |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Popis: |
Guidelines for previous negative biopsy (PNB) cohorts with a suspicion of prostate cancer (PCa) after positive multiparametric (mp) magnetic-resonance-imaging (MRI) often favour the fusion-guided targeted prostate-biopsy (TB) only approach for Prostate Imaging-Reporting and Data System (PI-RADS) ≥3 lesions. However, recommendations lack direct biopsy performance comparison within biopsy naïve (BN) vs. PNB patients and its prognostication of the whole mount pathology report (WMPR), respectively. We suppose, that the combination of TB and concomitant TRUS-systematic biopsy (SB) improves the PCa detection rate of PI-RADS 2, 3, 4 or 5 lesions and the International Society of Urological Pathology (ISUP)-grade predictability of the WMPR in BN- and PNB patients.Patients with suspicious mpMRI, elevated prostate-specific-antigen and/or abnormal digital rectal examination were included. All PI-RADS reports were intramurally reviewed for biopsy planning. We compared the PI-RADS score substratified TB, SB or combined approach (TB/SB) associated BN- and PNB-PCa detection rate. Furthermore, we assessed the ISUP-grade variability between biopsy cores and the WMPR.According to BN (Despite csPCa is more frequently found in BN patients, the TB/SB method always detected a significantly higher number of csPCa within PI-RADS 3, 4 or 5 reports of our BN and PNB group. The TB/SB strategy predicts the ISUP-grade best in the total and BN cohort and in general shows the lowest upgrading rates, emphasizing its value not only in BN but also PNB patients. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
